India, May 31 -- Samsung Electronics and Massachusetts General Hospital (MGH) Diabetes Research Center (DRC) today jointly announced a research study to investigate the efficacy of Galaxy Watch in assisting adults starting GLP-1RA1 therapy to monitor and potentially manage muscle loss.

With nearly one in five adults in the US saying they have taken GLP-1 medication, this innovative clinical study will investigate how continuous data from Galaxy Watch can help patients and clinicians monitor and mitigate muscle loss by providing a clearer, more holistic view of a person's body composition and activity levels during treatment.

This research will delve into the feasibility of managing muscle loss for GLP-1 patients by utilizing biometric d...